Target Name: GIPC3
NCBI ID: G126326
Other Name(s): GIPC3_HUMAN | DFNB72 | DFNB95 | PDZ domain-containing protein GIPC3 | GIPC PDZ domain containing family member 3 | PDZ domain containing protein GIPC3 | C19orf64 | DFNB15

GIPC3: A Protein with Potential as A Drug Target

GIPC3 (Glycophosphatidylinositol-3-carboxylate) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and peripheral tissues. It is a key regulator of cell signaling and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of GIPC3 is its ability to interact with various signaling molecules, including G protein-coupled receptors (GPCRs) and ion channels. This interaction allows GIPC3 to regulate a wide range of cellular processes, including cell adhesion, migration, and survival.

GIPC3 has also been shown to play a role in modulating inflammation. It has been shown to reduce inflammation in various tissues, including the brain, which is thought to be a key site for the regulation of inflammation.

GIPC3 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. It has been shown to promote the growth and survival of cancer cells, and to inhibit the growth and survival of cancer cells.

GIPC3 is also a good candidate as a drug target. Its interaction with GPCRs and its role in modulating inflammation make it a potential target for small molecules, antibodies, or other therapeutic agents that can modulate its activity.

GIPC3 is a protein that has been studied extensively, and a number of studies have identified its various functions and interactions. However, much of its biology remains un understood, and it is still a challenging target for research and development.

In conclusion, GIPC3 is a protein that has the potential to be a drug target or biomarker. Its unique ability to interact with various signaling molecules and its role in modulating inflammation make it a promising target for small molecules, antibodies, or other therapeutic agents. Further research is needed to fully understand its biology and to develop effective treatments for the various diseases that are associated with its dysfunction.

Protein Name: GIPC PDZ Domain Containing Family Member 3

Functions: Required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion

More Common Targets

GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L | GLB1L2 | GLB1L3 | GLC1C | GLCCI1 | GLCCI1-DT | GLCE | GLDC | GLDN | GLE1 | GLG1 | GLI1 | GLI2 | GLI3 | GLI4 | GLIDR | GLIPR1 | GLIPR1L1 | GLIPR1L2 | GLIPR2 | GLIS1 | GLIS2 | GLIS3 | GLIS3-AS1 | GLMN | GLMP | GLO1 | GLOD4 | GLOD5 | GLP1R | GLP2R | GLRA1 | GLRA2 | GLRA3 | GLRA4 | GLRB | GLRX | GLRX2 | GLRX3 | GLRX3P2 | GLRX5 | GLS | GLS2 | GLT1D1 | GLT6D1 | GLT8D1 | GLT8D2 | GLTP | GLTPD2 | Glucagon-like peptide receptor (GLP-R) | Glucosidase | GLUD1 | GLUD1P2 | GLUD1P3 | GLUD2 | GLUL | GLULP2 | GLULP4 | Glutamate receptor | Glutamate Receptor Ionotropic | Glutamate Receptor Ionotropic AMPA Receptor | Glutamate Transporter | Glutaminase | Glutathione peroxidase | Glutathione S-Transferase (GST)